ERAS

Erasca, Inc.NASDAQHealthcare

$17.81+7.29%ClosedMarket Cap: $5.54B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-18	JP Morgan	—	Overweight	—
2026-03-16	Guggenheim	—	Buy	—
2026-03-13	Mizuho	—	Outperform	—
2026-03-13	Piper Sandler	—	Overweight	—
2026-03-13	HC Wainwright & Co.	—	Buy	—
2026-03-06	Clear Street	—	Buy	—
2026-01-26	HC Wainwright & Co.	—	Buy	—
2026-01-16	Piper Sandler	—	Overweight	—
2025-12-09	Mizuho	—	Outperform	—
2025-11-14	Guggenheim	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.52	$428.6K	7
Sun Dec 31	$-0.66	$3.7M	6
Mon Dec 31	$-0.77	$35.3M	4
Tue Dec 31	$-0.40	$299.3M	2